SBBP
Strongbridge Biopharma plc.
SBBP
SBBP
Delisted
SBBP was delisted on the 5th of October, 2021.
51 hedge funds and large institutions have $135M invested in Strongbridge Biopharma plc. in 2019 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
14% more capital invested
Capital invested by funds: $119M → $135M (+$16.4M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $26K
Holders
51
Holding in Top 10
2
Calls
–
Puts
$26K
Top Buyers
| 1 | +$4.55M | |
| 2 | +$2M | |
| 3 | +$932K | |
| 4 |
TI
Telemetry Investments
New York
|
+$620K |
| 5 |
Goldman Sachs
New York
|
+$384K |
Top Sellers
| 1 | -$2.44M | |
| 2 | -$1.92M | |
| 3 | -$1.18M | |
| 4 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$1.01M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$527K |